The hectic pace of pandemic care may contribute to medication errors. It's critical to recognize this risk by putting into place safeguards that support identifying and preventing these errors.
Recent statements issued by the New England Journal of Medicine and the Lancet share significant concern related to the credibility of two major studies evaluating the safety and efficacy of hydroxychloroquine to prevent and treat COVID-19.
To support policyholders as they resume operations, MLMIC has recorded a podcast with recommendations and key considerations for safely and effectively reopening.
A news report issued by the University of Minnesota’s Center for Infectious Disease Research and Policy shares concern related to extensive use of antibiotics to treat COVID-19, a practice that may be accelerating antibiotic resistance.